← Back to Clinical Trials
Recruiting NCT06481631

NCT06481631 Patient-clinical Linkages to Improve Trust and Engagement in Postpartum Healthcare

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06481631
Status Recruiting
Phase
Sponsor Jackson State University
Condition Family Dynamics
Study Type INTERVENTIONAL
Enrollment 250 participants
Start Date 2025-06-01
Primary Completion 2029-06-30

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 45 Years
Study Type INTERVENTIONAL
Interventions
The PEN-3 Intervention Model

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 250 participants in total. It began in 2025-06-01 with a primary completion date of 2029-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Maternal mortality in the United States is higher than in peer nations and has not decreased since 1990. Beyond mortality, severe maternal mortality impacts far too many women. Not only are these high rates alarming, but notable racial/ethnic and socioeconomic disparities exist. These inequities are highly regional, with women living in the rural southeast part of the United States, including the Mississippi Delta, having the highest rates of maternal mortality and morbidity. Unfortunately, these disparities have proven to be stubbornly resistant to interventions, necessitating an innovative multifaceted approach focused on community practice, building trust, and prioritizing patient voices. To meet this need, this proposal aims to establish the Mississippi Delta Research Center of Excellence for Maternal Health with the goal of addressing preventable maternal mortality, decreasing severe maternal morbidity, and promoting maternal health equity in partnership with the Mississippi Delta community. This patient-clinical linkages intervention study will evaluate the effectiveness of a multilevel and multisector communication and health literacy strategy to increase trust and engagement in postpartum healthcare among women in the Mississippi Delta, with a specific focus on Black women, their families, and their communities. These research projects both have the overarching goal of partnering with the community to determine and meet the needs of pregnant and postpartum women in the Mississippi Delta and address the disparities within maternity health and health care outcomes.

Eligibility Criteria

Inclusion Criteria: * Identified as high risk pregnancy * Postpartum mothers/parents 18-45 years * Resident of the one of 5 target counties (Washington, Bolivar, Scott, Humphreys, and Carroll) * Maternal healthcare providers in target counties * Maternal community health leaders Exclusion Criteria: * not identified as high risk pregnancy * 18 years of age postpartum * cesarean birth * non-resident of the 5 target counties

Contact & Investigator

Central Contact

Mary Shaw, PhD

✉ mary.shaw@jsums.edu

📞 601-979-3103

Principal Investigator

Mary Shaw, PhD

PRINCIPAL INVESTIGATOR

Jackson State University

Frequently Asked Questions

Who can join the NCT06481631 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Family Dynamics. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06481631 currently recruiting?

Yes, NCT06481631 is actively recruiting participants. Contact the research team at mary.shaw@jsums.edu for enrollment information.

Where is the NCT06481631 trial being conducted?

This trial is being conducted at Jackson, United States.

Who is sponsoring the NCT06481631 clinical trial?

NCT06481631 is sponsored by Jackson State University. The principal investigator is Mary Shaw, PhD at Jackson State University. The trial plans to enroll 250 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology